An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Public ClinicalTrials.gov record NCT00809965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients with a recent acute coronary syndrome compared with placebo.
Study identification
- NCT ID
- NCT00809965
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 15,526 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Sep 2011 (Actual)
- Completion
- Sep 2011 (Actual)
- Last update posted
- Sep 17, 2014
2008 – 2011
United States locations
- U.S. sites
- 73
- U.S. states
- 29
- U.S. cities
- 73
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Geneva | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Burbank | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Mission Hills | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Littleton | Colorado | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Rome | Georgia | — | — |
| Not listed | Aurora | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Merrillville | Indiana | — | — |
| Not listed | Munster | Indiana | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Lacombe | Louisiana | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Flint | Michigan | — | — |
| Not listed | Grand Blanc | Michigan | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Mount Clemens | Michigan | — | — |
| Not listed | Petoskey | Michigan | — | — |
| Not listed | Tupelo | Mississippi | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Kalispell | Montana | — | — |
| Not listed | Bridgewater | New Jersey | — | — |
| Not listed | Linden | New Jersey | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | Cortlandt Manor | New York | — | — |
| Not listed | Saratoga Springs | New York | — | — |
| Not listed | Stony Brook | New York | — | — |
| Not listed | Syracuse | New York | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Fairview Park | Ohio | — | — |
| Not listed | Bartlesville | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Langhorne | Pennsylvania | — | — |
| Not listed | Ridley Park | Pennsylvania | — | — |
| Not listed | Sayre | Pennsylvania | — | — |
| Not listed | West Chester | Pennsylvania | — | — |
| Not listed | York | Pennsylvania | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Johnson City | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | Tomball | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Burlington | Vermont | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Roanoke | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Wausau | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 483 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00809965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2014 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00809965 live on ClinicalTrials.gov.